| Stage | EL | % of rev | CL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $3.7B | 100.00% | $5.4B | 100.00% | CL ×1.45 |
| Gross profit | $2.8B | 75.72% | $3.2B | 60.22% | EL +15.5pp |
| Operating income | $408M | 10.98% | $1.1B | 20.26% | CL +9.3pp |
| Pre-tax income | $345M | 9.29% | $1.0B | 18.98% | CL +9.7pp |
| Net income | $233M | 6.27% | $779M | 14.51% | CL +8.2pp |
| Stage | EL | CL | Gap · A − B |
|---|---|---|---|
| Revenue | $3.7B100.00% | $5.4B100.00% | CL ×1.45 |
| Gross profit | 75.72%$2.8B | 60.22%$3.2B | EL +15.5pp |
| Operating income | 10.98%$408M | 20.26%$1.1B | CL +9.3pp |
| Pre-tax income | 9.29%$345M | 18.98%$1.0B | CL +9.7pp |
| Net income |
| 6.27%$233M |
| 14.51%$779M |
| CL +8.2pp |
No shared counterparties.